`

ENYO Pharma

Biotechnology Research

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$42.61M
size-icon Size
11 - 50

Frequently Asked Questions About ENYO Pharma

What does Enyo pharma do?+

ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor

What is Enyo pharma's industry? +

Enyo pharma operates in the Biotechnology research industry.

What is Enyo pharma's revenue? +

Enyo pharma's revenue is 11m - 100m

What is Enyo pharma's company size? +

Enyo pharma has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.